Delayed
Bombay S.E.
10:27:34 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
72.25
INR
|
-0.41%
|
|
-4.97%
|
-12.76%
|
Fiscal Period: March |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,487
|
11,016
|
12,346
|
7,253
|
9,126
|
-
|
-
|
Enterprise Value (EV)
1 |
15,487
|
11,016
|
12,346
|
7,253
|
9,126
|
9,126
|
9,126
|
P/E ratio
|
11
x
|
-
|
-
|
19.1
x
|
121
x
|
19.6
x
|
12.6
x
|
Yield
|
-
|
0.89%
|
0.79%
|
-
|
1.38%
|
1.38%
|
1.38%
|
Capitalization / Revenue
|
1.08
x
|
0.9
x
|
0.6
x
|
0.46
x
|
0.65
x
|
0.52
x
|
0.47
x
|
EV / Revenue
|
1.08
x
|
0.9
x
|
0.6
x
|
0.46
x
|
0.65
x
|
0.52
x
|
0.47
x
|
EV / EBITDA
|
6.21
x
|
13
x
|
5.21
x
|
5.44
x
|
9.03
x
|
5.51
x
|
4.6
x
|
EV / FCF
|
-
|
-5.76
x
|
-7.15
x
|
-
|
-7.4
x
|
-8.83
x
|
48.8
x
|
FCF Yield
|
-
|
-17.4%
|
-14%
|
-
|
-13.5%
|
-11.3%
|
2.05%
|
Price to Book
|
-
|
1.13
x
|
1.17
x
|
-
|
0.85
x
|
0.82
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
122,189
|
122,330
|
122,482
|
125,623
|
125,790
|
-
|
-
|
Reference price
2 |
126.8
|
90.05
|
100.8
|
57.74
|
72.55
|
72.55
|
72.55
|
Announcement Date
|
21/05/19
|
24/06/21
|
27/05/22
|
30/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
14,369
|
12,264
|
20,506
|
15,743
|
13,948
|
17,390
|
19,403
|
EBITDA
1 |
2,495
|
845.8
|
2,369
|
1,333
|
1,011
|
1,656
|
1,982
|
EBIT
1 |
-
|
541
|
1,903
|
-
|
601
|
1,162
|
1,658
|
Operating Margin
|
-
|
4.41%
|
9.28%
|
-
|
4.31%
|
6.68%
|
8.55%
|
Earnings before Tax (EBT)
1 |
2,192
|
553.8
|
1,420
|
508.4
|
103.5
|
619.5
|
962
|
Net income
1 |
1,413
|
419.8
|
1,077
|
380.3
|
76.5
|
464
|
721
|
Net margin
|
9.83%
|
3.42%
|
5.25%
|
2.42%
|
0.55%
|
2.67%
|
3.72%
|
EPS
2 |
11.54
|
-
|
-
|
3.030
|
0.6000
|
3.700
|
5.750
|
Free Cash Flow
1 |
-
|
-1,911
|
-1,726
|
-
|
-1,234
|
-1,034
|
187
|
FCF margin
|
-
|
-15.59%
|
-8.42%
|
-
|
-8.85%
|
-5.95%
|
0.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
9.43%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
25.94%
|
Dividend per Share
2 |
-
|
0.8000
|
0.8000
|
-
|
1.000
|
1.000
|
1.000
|
Announcement Date
|
21/05/19
|
24/06/21
|
27/05/22
|
30/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q1
|
2022 Q3
|
2022 Q4
|
2024 Q3
|
---|
Net sales
1 |
-
|
5,618
|
5,973
|
3,550
|
EBITDA
1 |
-
|
683.3
|
538
|
266
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
381.2
|
-
|
-
|
-
|
Net income
1 |
298.6
|
200.5
|
-
|
27
|
Net margin
|
-
|
3.57%
|
-
|
0.76%
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/08/21
|
11/02/22
|
27/05/22
|
-
|
Fiscal Period: March |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-1,911
|
-1,726
|
-
|
-1,234
|
-1,034
|
187
|
ROE (net income / shareholders' equity)
|
18.5%
|
4.4%
|
10.6%
|
3.57%
|
0.7%
|
4.2%
|
6.2%
|
ROA (Net income/ Total Assets)
|
11.9%
|
-
|
-
|
1.79%
|
0.3%
|
1.9%
|
2.4%
|
Assets
1 |
11,868
|
-
|
-
|
21,247
|
25,500
|
24,421
|
30,042
|
Book Value Per Share
2 |
-
|
79.70
|
86.20
|
-
|
85.20
|
88.20
|
94.10
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1,482
|
1,781
|
1,591
|
3,378
|
2,722
|
842
|
243
|
Capex / Sales
|
10.32%
|
14.52%
|
7.76%
|
21.45%
|
19.51%
|
4.84%
|
1.25%
|
Announcement Date
|
21/05/19
|
24/06/21
|
27/05/22
|
30/05/23
|
-
|
-
|
-
|
Last Close Price
72.55
INR Average target price
90
INR Spread / Average Target +24.05% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.76% | 109M | | +17.73% | 66.69B | | +17.45% | 41.24B | | +20.17% | 25.89B | | +11.67% | 19.81B | | +0.85% | 17.11B | | -21.87% | 15.86B | | +2.37% | 15.35B | | -10.29% | 15.23B | | -22.30% | 13.36B |
Other Specialty Chemicals
|